BID | BH3 interacting domain death agonist | Mitochondrial proteins
| | | | | Expressed in all |
HIRA | Histone cell cycle regulator | | | | | | Expressed in all |
COMT | Catechol-O-methyltransferase | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
SDF2L1 | Stromal cell-derived factor 2-like 1 | Predicted secreted proteins
| | | | | Expressed in all |
SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MIF | Macrophage migration inhibitory factor (glycosylation-inhibiting factor) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
TPST2 | Tyrosylprotein sulfotransferase 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
EWSR1 | EWS RNA-binding protein 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MCM5 | Minichromosome maintenance complex component 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MB | Myoglobin | Candidate cardiovascular disease genes Plasma proteins
| | | | | Group enriched |
RBFOX2 | RNA binding protein, fox-1 homolog (C. elegans) 2 | | | | | | Mixed |
APOL2 | Apolipoprotein L, 2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
TXN2 | Thioredoxin 2 | Mitochondrial proteins
| | | | | Expressed in all |
PVALB | Parvalbumin | | | | | | Group enriched |
SH3BP1 | SH3-domain binding protein 1 | Predicted secreted proteins
| | | | | Mixed |
LGALS1 | Lectin, galactoside-binding, soluble, 1 | Plasma proteins
| | | | | Expressed in all |
TRIOBP | TRIO and F-actin binding protein | Disease related genes Plasma proteins
| | | | | Expressed in all |
H1F0 | H1 histone family, member 0 | Plasma proteins
| | | | | Expressed in all |
POLR2F | Polymerase (RNA) II (DNA directed) polypeptide F | RNA polymerase related proteins
| | | | | Expressed in all |
DDX17 | DEAD (Asp-Glu-Ala-Asp) box helicase 17 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
TOMM22 | Translocase of outer mitochondrial membrane 22 homolog (yeast) | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
SUN2 | Sad1 and UNC84 domain containing 2 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
RPL3 | Ribosomal protein L3 | FDA approved drug targets Plasma proteins Predicted secreted proteins Ribosomal proteins
| | | | | Expressed in all |
ADSL | Adenylosuccinate lyase | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
EP300 | E1A binding protein p300 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
RANGAP1 | Ran GTPase activating protein 1 | Plasma proteins
| | | | | Expressed in all |
PHF5A | PHD finger protein 5A | Transcription factors
| | | | | Expressed in all |
ACO2 | Aconitase 2, mitochondrial | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
SMDT1 | Single-pass membrane protein with aspartate-rich tail 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CYB5R3 | Cytochrome b5 reductase 3 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
FBLN1 | Fibulin 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
TYMP | Thymidine phosphorylase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |